Literature DB >> 10817152

NMR of glycogen in exercise.

T B Price1, D L Rothman, R G Shulman.   

Abstract

Natural-abundance 13C NMR spectroscopy is a non-invasive technique that enables in vivo assessments of muscle and/or liver glycogen concentrations. Over the last several years, 13C NMR has been developed and used to obtain information about human glycogen metabolism with diet and exercise. Since NMR is non-invasive, more data points are available over a specified time course, dramatically improving the time resolution. This improved time resolution has enabled the documentation of subtleties of muscle glycogen re-synthesis following severe glycogen depletion that were not previously observed. Muscle and liver glycogen concentrations have been tracked in several different human populations under conditions that include: (1) muscle glycogen recovery from intense localized exercise with normal insulin and with insulin suppressed; (2) muscle glycogen recovery in an insulin-resistant population; (3) muscle glycogen depletion during prolonged low-intensity exercise; (4) effect of a mixed meal on postprandial muscle and liver glycogen synthesis. The present review focuses on basic 13C NMR and gives results from selected studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10817152     DOI: 10.1017/s0029665199001159

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  4 in total

1.  Stretching before exercise: an evidence based approach.

Authors:  I Shrier
Journal:  Br J Sports Med       Date:  2000-10       Impact factor: 13.800

2.  Magnetic resonance technology in training and sports.

Authors:  T B Price
Journal:  Br J Sports Med       Date:  2000-10       Impact factor: 13.800

3.  Magnetic resonance spectroscopy studies of human metabolism.

Authors:  Douglas E Befroy; Gerald I Shulman
Journal:  Diabetes       Date:  2011-05       Impact factor: 9.461

Review 4.  Exercise therapy in type 2 diabetes.

Authors:  Stephan F E Praet; Luc J C van Loon
Journal:  Acta Diabetol       Date:  2009-05-29       Impact factor: 4.280

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.